Keywords
off-label use
foreign medicine
compassionate use drug
foreign medicine
compassionate use drug
How to Cite
Garcia de Andoin Barandiaran, J., Umerez Igartua, M., Ercilla Liceaga, M., Landa Alberdi, J., Leunda Eizmendi, L., Urretavizcaya Anton, M., & Lizardi Mutuberria, A. (2021). What can we do when the pharmaceutical-provision of the public health system doesn’t include the medications for our patient clinical needs?. Osagaiz: Osasun-Zientzien Aldizkaria, 5(1). Retrieved from https://aldizkariak.ueu.eus/index.php/osagaiz/article/view/366
Abstract
There may be situations where the clinical needs of a patient can not be covered with a drug included in the pharmaceutical-provision of the public health system. There are different options for obtaining it: off-label use, acquisition of a foreign medicine, compassionate use of research drug or participation in a clinical trial. In these cases, a special request must be made to the Spanish Agency for Medicines and Health Products and/or to the hospital authorities. The reports to be submitted will clearly state the essential need for the drug and it is also mandatory to obtain informed consent from the patient.